SCHEMBL30366120

SCHEMBL30366120

Cn1cnc2c(N3CCOCC3)nc(Cl)nc21

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.60
CDK1 P06493 3/20 0.51
YTHDC1 Q96MU7 1/20 0.49
NT5E P21589 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
HDAC1 Q13547 2/20 0.43
MTOR P42345 1/20 0.43
ADORA1 P30542 1/20 0.43
TLR7 Q9NYK1 1/20 0.42
PDE10A Q9Y233 3/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL358366 1.00 PIK3CA (0.60) PIK3CACDK1YTHDC1NT5ESMN1; SMN2
SCHEMBL13828421 0.85 ADORA1 (0.56) PIK3CACDK1YTHDC1SMN1; SMN2ADORA1
SCHEMBL7299820 0.83 CDK1 (0.51) PIK3CACDK1YTHDC1ADORA1TLR7
SCHEMBL13828322 0.83 PIK3CA (0.60) PIK3CAHDAC1MTORADORA1TLR7
SCHEMBL13828332 0.83 PIK3CA (0.71) PIK3CACDK1HDAC1MTORADORA1
SCHEMBL24955551 0.83 PIK3CA (0.60) PIK3CACDK1HDAC1MTORADORA1
SCHEMBL13828313 0.83 PIK3CA (0.60) PIK3CAHDAC1MTORADORA1TLR7
SCHEMBL30439903 0.82 TLR7 (0.50) PIK3CANT5ESMN1; SMN2HDAC1MTOR
SCHEMBL2395003 0.82 TLR7 (0.50) PIK3CANT5ESMN1; SMN2HDAC1MTOR
Hydrochloric Acid SCHEMBL7330227 0.82 CDK1 (0.50) PIK3CACDK1YTHDC1ADORA1TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119031913-A Purine and methods of use thereof 奇尼塔公司 2024-11-26 CN disclosed
CN-112920199-B Piperazinone substituent or derivative thereof, preparation method and application thereof, and pharmaceutical composition 四川大学 2023-02-03 CN disclosed